Attention-deficit/hyperactivity disorder (ADHD) in adults occurs at a prevalence rate that is higher than the prevalence of many major psychiatric disorders in adults. Thus, adult patients with ADHD often present with comorbid conditions, each of which alters the course of ADHD, overall treatment recommendations, and symptom response differently. Common ADHD comorbidities include major depressi...

Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for attention deficit/hyperactivity disorder (ADHD) specify two dimensions of inattention and hyperactivity-impulsivity symptoms that are used to define three nominal subtypes: predominantly hyperactive-impulsive type (ADHD-H), predominantly inattentive type (ADHD-I), and combined type (ADHD-C). To aid decision...

objectives : the aim of this randomized clinical trial was to assess the efficacy of memantine versus methylphenidate in the treatment of children with attention deficit hyperactivity disorder. method : forty participants (34 boys and 6 girls) aged 6-11 who were diagnosed with attention deficit hyperactivity disorder based on (dsm-iv-tr) criteria were selected for this study. the participants w...

objective: attention deficit hyperactivity disorder (adhd) is a chronic, highly prevalent neurodevelopmental disorder which affects 9% of school-age children. triple p-positive parenting program is an evidence-based parenting program reported to be useful in the management of this disorder. the aim of this randomized controlled trial was to evaluate the effectiveness of triple p in mothers of a...

Attention deficit hyperactivity disorder (ADHD) is a childhood-onset psychiatric disorder whose cardinal symptoms are inattention, hyperactivity and impulsivity1. Diagnostic criteria for ADHD are based on extensive empirical research and appropriately lead to the diagnosis of a syndrome with higher interrater reliability, high predictability of course and medication responsiveness. The criteria...

Approximately, one-third of male adolescents in treatment for a substance use disorder (SUD) also have an Attention-Deficit Hyperactivity Disorder (ADHD). This strongly suggests that ADHD is a major risk factor for the development of SUD which practitioners must address if they are to provide adequate treatment for adolescents with SUD/ADHD. This paper supports a causal role for ADHD in the dev...

This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacolo...

This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacolo...

This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacolo...

This practice parameter describes the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder (ADHD) based on the current scientific evidence and clinical consensus of experts in the field. This parameter discusses the clinical evaluation for ADHD, comorbid conditions associated with ADHD, research on the etiology of the disorder, and psychopharmacolo...